Literature DB >> 29483760

AGE-RAGE Stress, Stressors, and Antistressors in Health and Disease.

Kailash Prasad1, Manish Mishra1.   

Abstract

Adverse effects of advanced glycation end-products (AGEs) on the tissues are through nonreceptor- and receptor-mediated mechanisms. In the receptor-mediated mechanism, interaction of AGEs with its cell-bound receptor of AGE (RAGE) increases generation of oxygen radicals, activates nuclear factor-kappa B, and increases expression and release of pro-inflammatory cytokines resulting in the cellular damage. The deleterious effects of AGE and AGE-RAGE interaction are coined as "AGE-RAGE stress." The body is equipped with defense mechanisms to counteract the adverse effects of AGE and RAGE through endogenous enzymatic (glyoxalase 1, glyoxalase 2) and AGE receptor-mediated (AGER1, AGER2) degradation of AGE, and through elevation of soluble receptor of AGE (sRAGE). Exogenous defense mechanisms include reduction in consumption of AGE, prevention of AGE formation, and downregulation of RAGE expression. We have coined AGE and RAGE as "stressors" and the defense mechanisms as "anti-stressors." AGE-RAGE stress is defined as a shift in the balance between stressors and antistressors in the favor of stressors. Measurements of stressors or antistressors alone would not assess AGE-RAGE stress. For true assessment of AGE-RAGE stress, the equation should include all the stressors and antistressors. The equation for AGE-RAGE stress, therefore, would be the ratio of AGE + RAGE/sRAGE + glyoxalase1 + glyoxalase 2 + AGER1 +AGER2. This is, however, not practical in patients. AGE-RAGE stress may be assessed simply by the ratio of AGE/sRAGE. A high ratio of AGE/sRAGE indicates a relative shift in stressors from antistressors, suggesting the presence of AGE-RAGE stress, resulting in tissue damage, initiation, and progression of the diseases and their complications.

Entities:  

Keywords:  AGER1; AGER2; AGE–RAGE stress; advanced glycation end-products (AGE); antistressors; glyoxalase 1; glyoxalase 2; receptor for AGE (RAGE); soluble receptor for AGE (sRAGE); stressors

Year:  2017        PMID: 29483760      PMCID: PMC5825221          DOI: 10.1055/s-0037-1613678

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  137 in total

1.  Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis.

Authors:  S D Yan; H Zhu; A Zhu; A Golabek; H Du; A Roher; J Yu; C Soto; A M Schmidt; D Stern; M Kindy
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

2.  Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases.

Authors:  A Taguchi; D C Blood; G del Toro; A Canet; D C Lee; W Qu; N Tanji; Y Lu; E Lalla; C Fu; M A Hofmann; T Kislinger; M Ingram; A Lu; H Tanaka; O Hori; S Ogawa; D M Stern; A M Schmidt
Journal:  Nature       Date:  2000-05-18       Impact factor: 49.962

3.  Presence of diabetic complications in type 1 diabetic patients correlates with low expression of mononuclear cell AGE-receptor-1 and elevated serum AGE.

Authors:  C J He; T Koschinsky; C Buenting; H Vlassara
Journal:  Mol Med       Date:  2001-03       Impact factor: 6.354

4.  N epsilon-(carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins.

Authors:  S Reddy; J Bichler; K J Wells-Knecht; S R Thorpe; J W Baynes
Journal:  Biochemistry       Date:  1995-08-29       Impact factor: 3.162

5.  Glycation of low-density lipoproteins by methylglyoxal and glycolaldehyde gives rise to the in vitro formation of lipid-laden cells.

Authors:  B E Brown; R T Dean; M J Davies
Journal:  Diabetologia       Date:  2005-01-20       Impact factor: 10.122

6.  Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1.

Authors:  Nadjat Ouslimani; Meriem Mahrouf; Jacqueline Peynet; Dominique Bonnefont-Rousselot; Claudine Cosson; Alain Legrand; Jean-Louis Beaudeux
Journal:  Metabolism       Date:  2007-03       Impact factor: 8.694

Review 7.  Advanced glycation endproducts--role in pathology of diabetic complications.

Authors:  Nessar Ahmed
Journal:  Diabetes Res Clin Pract       Date:  2005-01       Impact factor: 5.602

8.  Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.

Authors:  U P Steinbrecher; J L Witztum
Journal:  Diabetes       Date:  1984-02       Impact factor: 9.461

9.  Modulation of advanced glycation end products by candesartan in patients with diabetic kidney disease--a dose-response relationship study.

Authors:  Sandeep A Saha; Brian K LaSalle; G Dennis Clifton; Robert A Short; Katherine R Tuttle
Journal:  Am J Ther       Date:  2010 Nov-Dec       Impact factor: 2.688

Review 10.  Advanced glycation end product cross-linking: pathophysiologic role and therapeutic target in cardiovascular disease.

Authors:  Susan Zieman; David Kass
Journal:  Congest Heart Fail       Date:  2004 May-Jun
View more
  21 in total

1.  AGE-RAGE Stress in the Pathophysiology of Atrial Fibrillation and Its Treatment.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2019-12-09

Review 2.  AGE-RAGE stress: a changing landscape in pathology and treatment of Alzheimer's disease.

Authors:  Kailash Prasad
Journal:  Mol Cell Biochem       Date:  2019-05-11       Impact factor: 3.396

Review 3.  Does AGE-RAGE Stress Play a Role in the Development of Coronary Artery Disease in Obesity?

Authors:  Kailash Prasad; Amal S Khan; Kalpana K Bhanumathy
Journal:  Int J Angiol       Date:  2022-02-12

Review 4.  The Effects of Dietary Advanced Glycation End-Products on Neurocognitive and Mental Disorders.

Authors:  Nathan M D'Cunha; Domenico Sergi; Melissa M Lane; Nenad Naumovski; Elizabeth Gamage; Anushri Rajendran; Matina Kouvari; Sarah Gauci; Thusharika Dissanayka; Wolfgang Marx; Nikolaj Travica
Journal:  Nutrients       Date:  2022-06-10       Impact factor: 6.706

5.  AGE-RAGE Stress in the Pathophysiology of Pulmonary Hypertension and its Treatment.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2019-04-19

6.  Prevalence, Incidence, and Risk Factors for Overall, Physical, and Cognitive Independence Among Those From Exceptionally Long-Lived Families: The Long Life Family Study.

Authors:  Adam J Santanasto; Megan M Marron; Robert M Boudreau; Mary F Feitosa; Mary K Wojczynski; Konstantin G Arbeev; Bharat Thyagarajan; Nicole Schupf; Eric Stallard; Paola Sebastiani; Stephanie Cosentino; Kaare Christensen; Anne B Newman
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-04-17       Impact factor: 6.053

Review 7.  Is carbonyl/AGE/RAGE stress a hallmark of the brain aging?

Authors:  Halyna Semchyshyn
Journal:  Pflugers Arch       Date:  2021-03-19       Impact factor: 3.657

Review 8.  AGE-RAGE Stress and Coronary Artery Disease.

Authors:  Kailash Prasad
Journal:  Int J Angiol       Date:  2021-01-21

Review 9.  Interacting Models of Amyloid-β and Tau Proteins: An Approach to Identify Drug Targets in Alzheimer's Disease.

Authors:  Khadgawat Priya; J M Siddesha; Shashank Dharini; K Prasad Shashanka
Journal:  J Alzheimers Dis Rep       Date:  2021-05-14

10.  Circulating Advanced Glycation End Products and Their Soluble Receptors in Relation to All-Cause and Cardiovascular Mortality: A Systematic Review and Meta-analysis of Prospective Observational Studies.

Authors:  Elham Sharifi-Zahabi; Fatemeh Hajizadeh Sharafabad; Hadi Abdollahzad; Mahsa Malekahmadi; Nadya Bahari Rad
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 11.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.